TRANSMEDICS GROUP INC (TMDX)

US89377M1099 - Common Stock

76.04  -3.3 (-4.16%)

After market: 75.99 -0.05 (-0.07%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
30.26M
18.02%		93.46M
208.86%		241.623M
158.53%		442.77M
83.25%
EBITDA
YoY % growth
-37.61M
-51.65%		-27.96M
25.66%		8.662M
130.98%		66.905M
672.40%
EBIT
YoY % growth
-39.43M
-49.47%		-31.44M
20.26%		485K
101.54%		47.482M
9,690.10%
Operating Margin
-130.30%-33.64%0.20%10.72%
EPS
YoY % growth
-1.61
-34.17%		-1.25
22.36%		-0.77
38.40%		1.09
241.45%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.23
90.77%
Revenue
Q2Q % growth		115.7M
42.53%
EBITDA
Q2Q % growth		17.397M
61.38%
EBIT
Q2Q % growth		7.849M
201.54%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 0.12
115.38%		0.30-0.18-59.86%
Q2 2024
Q2Q % growth		 0.35
1,266.67%		0.210.1463.40%
Q1 2024
Q2Q % growth		 0.35
537.50%		-0.040.39957.84%
Q4 2023
Q2Q % growth		 0.12
157.14%		-0.060.18289.75%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 108.761M
63.72%		117.3M-8.539M-7.28%
Q2 2024
Q2Q % growth		 114.305M
117.87%		100.95M13.355M13.23%
Q1 2024
Q2Q % growth		 96.85M
133.07%		85.453M11.397M13.34%
Q4 2023
Q2Q % growth		 81.174M
158.68%		69.877M11.297M16.17%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS136.25% 136.25% -15.69% 33.26%
Revenue8.75% 8.75% -2.31% 8.14%